Finance
Provider to industry revises third and fourth quarter outlook
Published in Biotech Business Week, October 18th, 2004
Teleflex designs, manufactures and distributes quality engineered products and services for the medical, aerospace, automotive, marine and industrial markets worldwide.
The company now expects diluted earnings per share in the range of 38-40 cents for the 2004 third quarter, which represents earnings per share for the full year of $2.60 to $2.70.
These estimates reflect an anticipated decline of $5-7 million per quarter in the operating profits of the company's tier 1 automotive businesses, predominantly the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
More Articles from Biotech Business Week
- Advanced Cancer
HGS-ETR2 trials demonstrate safety, tolerability in advanced cancer patients - Anemia
Aranesp approved for extended dosing by European Commission - Infection Control
Tissue bank to provide sterile soft tissue allografts using gamma irradiation - Sexual Dysfunction
Positive results reported on phase II study of LibiGel - Urinary Tract Infection
Proquin XR New Drug Application accepted for review by U.S. FDA - African Sleeping Sickness
Enrollment completed for clinical trial of DB289 in African sleeping sickness - More from this issue of Biotech Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
